Filing Details
- Accession Number:
- 0001209191-19-001612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-03 21:03:04
- Reporting Period:
- 2018-12-31
- Accepted Time:
- 2019-01-03 21:03:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1390478 | Sellas Life Sciences Group Inc. | SLS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1724253 | M. Angelos Stergiou | C/O Sellas Life Sciences Group, Inc. 15 West 38Th Street, 10Th Floor New York NY 10018 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-12-31 | 23,277 | $1.25 | 426,858 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The Reporting Person sold such shares to cover personal income tax liability.
- The price reported is a weighted average price. The shares were sold at prices ranging from $1.23 to $1.31 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
